We describe here a method to obtain functional spinal and cranial motor neurons from human induced pluripotent stem cells (iPSCs). Direct conversion into motor neuron is obtained by ectopic expression of alternative modules of transcription factors, namely Ngn2, Isl1 and Lhx3 (NIL) or Ngn2, Isl1 and Phox2a (NIP). NIL and NIP specify, respectively, spinal and cranial motor neuron identity. Our protocol starts with the generation of modified iPSC lines in which NIL or NIP are stably integrated in the genome via a piggyBac transposon vector. Expression of the transgenes is then induced by doxycycline and leads, in 5 days, to the conversion of iPSCs into MN progenitors. Subsequent maturation, for 7 days, leads to homogeneous populations of spin...
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease, mainly affecting the moto...
Primary rodent neurons and immortalised cell lines have overwhelmingly been used for in vitro studie...
International audienceModelling rare neurogenetic diseases to develop new therapeutic strategies is ...
Human pluripotent stem cells (PSCs) are widely used for in vitro disease modeling. One of the challe...
Objectives: Transplantation of neural progenitor cells (NPCs) derived from human-induced pluripotent...
Generation of motor neurons (MNs) from human-induced pluripotent stem cells (hiPSCs) overcomes the l...
There are no cures or efficacious treatments for severe motor neuron diseases. It is extremely diffi...
Motor neurons (MNs) derived from human-induced pluripotent stem cells (hiPSC) hold great potential f...
SummaryAvailable methods for differentiating human embryonic stem cells (ESCs) and induced pluripote...
Cell replacement using stem cells is a promising therapeutic approach to treat degenerative motor ne...
BACKGROUND: There are no cures or efficacious treatments for severe motor neuron diseases. It is ext...
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder and a leading gen...
Limited access to human neurons, especially motor neurons (MNs), was a major challenge for studying ...
Embryonic stem cells are pluripotent cells with the potential to differentiate into any cell type in...
Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases that cause infa...
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease, mainly affecting the moto...
Primary rodent neurons and immortalised cell lines have overwhelmingly been used for in vitro studie...
International audienceModelling rare neurogenetic diseases to develop new therapeutic strategies is ...
Human pluripotent stem cells (PSCs) are widely used for in vitro disease modeling. One of the challe...
Objectives: Transplantation of neural progenitor cells (NPCs) derived from human-induced pluripotent...
Generation of motor neurons (MNs) from human-induced pluripotent stem cells (hiPSCs) overcomes the l...
There are no cures or efficacious treatments for severe motor neuron diseases. It is extremely diffi...
Motor neurons (MNs) derived from human-induced pluripotent stem cells (hiPSC) hold great potential f...
SummaryAvailable methods for differentiating human embryonic stem cells (ESCs) and induced pluripote...
Cell replacement using stem cells is a promising therapeutic approach to treat degenerative motor ne...
BACKGROUND: There are no cures or efficacious treatments for severe motor neuron diseases. It is ext...
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder and a leading gen...
Limited access to human neurons, especially motor neurons (MNs), was a major challenge for studying ...
Embryonic stem cells are pluripotent cells with the potential to differentiate into any cell type in...
Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases that cause infa...
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease, mainly affecting the moto...
Primary rodent neurons and immortalised cell lines have overwhelmingly been used for in vitro studie...
International audienceModelling rare neurogenetic diseases to develop new therapeutic strategies is ...